Literature DB >> 12042543

Natural history and familial relationships of infant spilling to 9 years of age.

A James Martin1, Nicole Pratt, J Declan Kennedy, Philip Ryan, Richard E Ruffin, Helen Miles, John Marley.   

Abstract

OBJECTIVES: To determine the natural history of infant spilling (regurgitation/vomiting) during the first 2 years of life and to determine the relationship between infant spilling and gastroesophageal reflux (GER) symptoms at 9 years of age.
METHODS: A prospective birth cohort was followed with daily symptom diaries during the first 2 years of life and reviewed at 9 years of age (range: 8-11 years). The prevalence of infant spilling during the first 2 years of life, the prevalence of GER symptoms between 8 and 11 years of age (mean age: 9.7 years), relative risk of infant spilling predisposing to GER symptoms at 9 years of age, and prevalence of maternal GER symptoms and relationship with infant spilling and GER at 9 years of age were measured.
RESULTS: A total of 693 children who represented 83% of an original sample of 836 children and were followed for 2 years from birth with daily symptom diaries were contacted at 9 (8-11) years of age. Spilling of most feeds each day was common in infancy and reached a peak prevalence of 41% between 3 and 4 months of age and thereafter declined to < 5% between 13 and 14 months of age. Infants with spilling on 90 days or more during the first 2 years of life (classified as frequent spilling) were more likely to have GER symptoms at 9 years of age. Children with frequent infant spilling, compared with those with no spilling, had a relative risk of 2.3 (95% confidence interval [CI]: 1.3-4.0) of 1 or more GER symptoms at 9 years of age, 4.6 (95% CI: 1.5-13.8) for heartburn, 2.7 (95% CI: 1.4-5.5) for vomiting, and 4.7 (95% CI: 1.6-14.0) for acid regurgitation. Gender, breastfeeding, and environmental tobacco smoke exposure were not significant factors related to infant spilling. Prepregnancy smoking and smoking in the same room as the child at the 9-month and 18-month follow-ups had a significant effect on GER symptoms at 9 years of age. Infant spilling and GER at 9 years of age were significantly related to maternal GER symptoms but not to paternal GER symptoms.
CONCLUSIONS: Spilling in infancy is very common, but the majority of children settle by 13 to 14 months of age. However, those with frequent spilling (>90 days) are more likely to have GER symptoms at 9 years of age. In addition, a maternal history of GER was significantly related both to infant spilling and to GER at 9 years, suggesting that a genetic component may be involved. Physicians should consider studying children with a history of frequent infant spilling to determine whether this group is at increased risk for GER disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12042543     DOI: 10.1542/peds.109.6.1061

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  40 in total

Review 1.  Therapeutic upper gastrointestinal tract endoscopy in Paediatric Gastroenterology.

Authors:  Imdadur Rahman; Praful Patel; Philip Boger; Shahnawaz Rasheed; Mike Thomson; Nadeem Ahmad Afzal
Journal:  World J Gastrointest Endosc       Date:  2015-03-16

Review 2.  Gastroesophageal reflux disease in neonates and infants : when and how to treat.

Authors:  Steven J Czinn; Samra Blanchard
Journal:  Paediatr Drugs       Date:  2013-02       Impact factor: 3.022

3.  Prevalence and associated features of gastroesophageal reflux symptoms in a Caucasian-predominant adolescent school population.

Authors:  T S Gunasekaran; Mary Dahlberg; Priya Ramesh; Ganesh Namachivayam
Journal:  Dig Dis Sci       Date:  2008-01-17       Impact factor: 3.199

Review 4.  GORD in children.

Authors:  Yadlapalli Kumar; Rajini Sarvananthan
Journal:  BMJ Clin Evid       Date:  2008-10-01

Review 5.  Current pharmacological management of gastro-esophageal reflux in children: an evidence-based systematic review.

Authors:  Mark P Tighe; Nadeem A Afzal; Amanda Bevan; R Mark Beattie
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

6.  Prevalence and management of gastroesophageal reflux disease in children and adolescents: a nationwide cross-sectional observational study.

Authors:  Léonie Martigne; Pierre-Henri Delaage; Florence Thomas-Delecourt; Geneviève Bonnelye; Philippe Barthélémy; Frédéric Gottrand
Journal:  Eur J Pediatr       Date:  2012-08-18       Impact factor: 3.183

7.  Gastroesophageal reflux symptoms in infants in a rural population: longitudinal data over the first six months.

Authors:  Robert S Van Howe; Michelle R Storms
Journal:  BMC Pediatr       Date:  2010-02-11       Impact factor: 2.125

8.  Gastroesophageal reflux disease: review of presenting symptoms, evaluation, management, and outcome in infants.

Authors:  Vasundhara Tolia; Anne Wuerth; Ronald Thomas
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

9.  Collagen type III alpha I is a gastro-oesophageal reflux disease susceptibility gene and a male risk factor for hiatus hernia.

Authors:  B Asling; J Jirholt; P Hammond; M Knutsson; A Walentinsson; G Davidson; L Agreus; A Lehmann; M Lagerström-Fermer
Journal:  Gut       Date:  2009-04-26       Impact factor: 23.059

10.  Tolerance of a standard intact protein formula versus a partially hydrolyzed formula in healthy, term infants.

Authors:  Carol Lynn Berseth; Susan Hazels Mitmesser; Ekhard E Ziegler; John D Marunycz; Jon Vanderhoof
Journal:  Nutr J       Date:  2009-06-19       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.